tiprankstipranks
Advertisement
Advertisement

Calix Withdraws Erroneous Appendix 3G on Unquoted Securities

Story Highlights
  • Calix Limited cancelled a previously filed Appendix 3G after determining it was issued in error.
  • The withdrawal aims to maintain accurate market disclosure and clarify that no valid new unquoted securities were issued.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Calix Withdraws Erroneous Appendix 3G on Unquoted Securities

Claim 30% Off TipRanks

Calix Ltd. ( (AU:CXL) ) just unveiled an update.

Calix Limited has clarified that a previous Appendix 3G filing to the ASX regarding the issue or conversion of unquoted securities was released in error. The company has now formally lodged a cancellation notice, effectively withdrawing the earlier document and indicating that the reported security issuance should not be relied upon by investors or other stakeholders.

The correction underscores Calix’s attempt to maintain accurate market disclosure and prevent confusion around its capital structure. While the announcement does not detail any change to underlying operations, it removes any implication that new unquoted securities have been validly issued, helping restore clarity for shareholders and market participants.

The most recent analyst rating on (AU:CXL) stock is a Sell with a A$0.78 price target. To see the full list of analyst forecasts on Calix Ltd. stock, see the AU:CXL Stock Forecast page.

More about Calix Ltd.

Calix Limited is an Australia-based company listed on the ASX under the code CXL. The specific industry, products, services, and market focus are not described in the provided announcement.

Average Trading Volume: 903,358

Technical Sentiment Signal: Sell

Current Market Cap: A$169.2M

See more insights into CXL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1